They did record it and will likely post on the website. Wasn't much more than a summary of the announcement.
Still talking about rapid commercialisation but no clear indication of exactly when products will hit the market other than they are working on it.
Once they start generating revenue I suspect this will re-rate.....hopefully no more raises prior to that.
All in my opinion.
Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-43
-
- There are more pages in this discussion • 226 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
